NCT02285959 2022-08-10
Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme
Global Neurosciences Institute
Phase 1 Unknown
Clinical Trials
9 trialsNCT05273814 2022-07-13
Study of Chemotherapy and PD-1 Inhibitor Combination With Anti-angiogenesis to Treat Elderly Lung Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 1 Unknown
NCT05363722 2022-05-06
A Clinical Study to Observe the Effectiveness and Safety of IBI310, Bevacizumab Combined With Sintilimab in the Treatment of Advanced Hepatocellular Carcinoma
Shanghai Zhongshan Hospital
Phase 1 Unknown
NCT00652119 2020-08-19
Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin
Massachusetts General Hospital
Phase 1 Unknown
NCT04175158 2019-11-22
Clinical Trial in Chinese Healthy Volunteers of GB222
Genor Biopharma Co., Ltd.
Phase 1 Unknown
NCT03631836 2018-08-17
MARELLE01
Assistance Publique Hopitaux De Marseille
Phase 1 Unknown
NCT02672995 2017-08-18
Fractionated Stereotactic Radiosurgery With Concurrent Bevacizumab for Brain Metastases: A Phase I Dose-escalation Trial
National Taiwan University Hospital
Phase 1 Unknown
NCT01880385 2013-06-19
Beva
Association Tunisienne de lutte Contre le Cancer
Phase 1 Unknown
NCT00318513 2006-05-10
Safety Study of Bevacizumab to Treat Women With a History of Breast Cancer and Suffering From Upper Extremity Lymphedema
Premiere Oncology of Arizona
Phase 1 Unknown